GE Healthcare Life Sciences offers technologies and services for the manufacture of biopharmaceuticals such as recombinant proteins, antibodies and vaccines. Our Xcellerex portfolio is commercializing turnkey biomanufacturing solutions that transform the speed and economics of producing therapeutic proteins, including biosimilars and vaccines.
Our Xcellerex portfolio also leverages its proprietary single-use technologies through the sale of XDR bioreactors, XDM Quad Mixers, and related single-use assemblies. To date, more than 20 therapeutic proteins and vaccines have been manufactured for clinical trials using Xcellerex technology.
Our FlexFactory solution is a complete modular and portable production train based on single-use technologies, advanced process automation, and compact clean room architecture. FlexFactory allows deployment of GMP manufacturing capacity more rapidly and at greatly reduced costs compared with traditional facilities.
Accelerate Your Time to Manufacturing
Through our BridgeSourcing services, we manufacture a partner’s biomolecules while the partner prepares for commissioning of its own new FlexFactory. When the partner’s facility is ready, we deploy the TransPlant process to install, validate, and train partner personnel in their own FlexFactory. This parallel-path model both accelerates time to clinical and commercial manufacturing and allows partners to manage the development and market risks associated with adding manufacturing capacity.
FlexFactory is a trademark of Xcellerex.